Gilead Sciences Inc (GILD)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	5,664,000	5,875,000	5,484,000	5,583,000	4,592,000	3,334,000	4,137,000	4,515,000	6,225,000	7,394,000	5,162,000	301,000	123,000	1,268,000	-257,000	4,962,000	5,386,000	2,693,000	5,955,000	5,892,000
Revenue (ttm)	US$ in thousands	26,229,000	26,516,000	26,520,000	26,161,000	26,413,000	26,256,000	26,613,000	26,496,000	26,325,000	26,743,000	26,144,000	25,341,000	24,689,000	23,147,000	22,174,000	22,716,000	22,449,000	22,365,000	22,357,000	22,320,000
Net profit margin		21.59%	22.16%	20.68%	21.34%	17.39%	12.70%	15.55%	17.04%	23.65%	27.65%	19.74%	1.19%	0.50%	5.48%	-1.16%	21.84%	23.99%	12.04%	26.64%	26.40%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $5,664,000K ÷ $26,229,000K
= 21.59%

The net profit margin of Gilead Sciences, Inc. has shown a generally positive trend over the past eight quarters. The margins have ranged from a low of 12.29% in Q3 2022 to a high of 21.45% in Q3 2023. This indicates that the company has been able to effectively control its expenses and generate higher profits in recent quarters. The most recent net profit margin of 20.89% in Q4 2023 is slightly lower than the previous quarter but remains at a healthy level, demonstrating strong profitability for the company. Overall, the consistent improvement in net profit margins reflects Gilead Sciences' ability to efficiently manage its operations and increase its bottom line performance over time.